Pharmacoki netics of ethylenediaminemalonatoplatinum (II) (JM 4O) during phase I Trial

F. Elferink, W.J.F. van der Vijgh, W.W. ten Bokkel Huinink, J.B. Vermorken, I. Klein, B. Winograd, M.K.T. Knobf, G. Simonetti, H.E. Gall, J.G. McVie, H.M. Pinedo

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)479-483
JournalBritish Journal of Cancer
Volume56
Publication statusPublished - 1987

Cite this

Elferink, F., van der Vijgh, W. J. F., ten Bokkel Huinink, W. W., Vermorken, J. B., Klein, I., Winograd, B., ... Pinedo, H. M. (1987). Pharmacoki netics of ethylenediaminemalonatoplatinum (II) (JM 4O) during phase I Trial. British Journal of Cancer, 56, 479-483.